Novartis AG
Utility Patent Applications
Last updated:
List of all Novartis AG patents 676 in total
| Status | Patent |
|---|---|
Application | Utility: THE USE OF AN MGLUR5 ANTAGONIST FOR TREATING OPIOID ANALGESIC TOLERANCE Filling date: 23 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: COMPUTER METHOD AND SYSTEM FOR DERIVING CELL-TO-CELL SPATIAL PROXIMITIES Filling date: 23 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: CHEMICAL PROCESS FOR PREPARING PHENYLPIPERIDINYL INDOLE DERIVATIVES Filling date: 23 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: METHODS OF TREATING FGF21-ASSOCIATED DISORDERS Filling date: 23 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: FACTOR XI ANTIBODIES AND METHODS OF USE Filling date: 23 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: CRYSTALLINE FORMS OF 4-(7-HYDROXY-2-ISOPROPYL-4-OXO-4H-QUINAZOLIN-3-YL)-BENZONITRILE AND FORMULATIONS THEREOF Filling date: 23 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND RIBOCICLIB Filling date: 23 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND A PD-1 INHIBITOR Filling date: 23 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: Choline Esters Filling date: 23 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: NOVEL USES OF PIPERIDINYL-INDOLE DERIVATIVES Filling date: 23 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3 Filling date: 23 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: COMPOSITIONS AND METHODS TO TREAT BIETTI CRYSTALLINE DYSTROPHY Filling date: 23 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: COMPOSITIONS AND METHODS TO TREAT BIETTI CRYSTALLINE DYSTROPHY Filling date: 23 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: MESOPOROUS SILICA PARTICLES COMPOSITIONS FOR VIRAL DELIVERY Filling date: 23 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: PHARMACEUTICAL COMBINATION COMPRISING TNO155 AND A KRASG12C INHIBITOR Filling date: 23 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: COMBINATION THERAPY Filling date: 23 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: OPTIMIZED LENTIVIRAL TRANSFER VECTORS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST Filling date: 23 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: 3-(1-OXO-5-(PIPERIDIN-4-YL)ISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: SUBSTITUTED 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: NEW MYOKINES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: FLOW-THROUGH PARAMAGNETIC PARTICLE-BASED CELL SEPARATION AND PARAMAGNETIC PARTICLE REMOVAL Filling date: 23 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3 Filling date: 23 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: PHARMACEUTICAL USE Filling date: 23 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE Filling date: 23 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: ISOXAZOLE CARBOXAMIDE COMPOUNDS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: LTA4H INHIBITORS FOR THE TREATMENT OF HIDRADENITIS SUPPURATIVA Filling date: 23 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS Filling date: 23 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: FUSED TRICYCLIC PYRAZOLO-DIHYDROPYRAZINYL-PYRIDONE COMPOUNDS AS ANTIVIRALS Filling date: 23 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: TECHNIQUE FOR DETERMINING A STATE OF MULTIPLE SCLEROSIS IN A PATIENT Filling date: 23 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: CYANOTRIAZOLE COMPOUNDS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: LIPOIC ACID CHOLINE ESTER COMPOSITIONS AND METHODS TO GENERATE BIOCOMPATIBLE OPHTHALMIC FORMULATIONS Filling date: 23 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: CAR-EXPRESSING CELLS AGAINST MULTIPLE TUMOR ANTIGENS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: SITE-SPECIFIC CHEMOENZYMATIC PROTEIN MODIFICATIONS Filling date: 23 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR INHBITING THE ACTIVITY OF SHP2 Filling date: 23 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: COMBINATION THERAPIES OF EGFRVIII CHIMERIC ANTIGEN RECEPTORS AND PD-1 INHIBITORS Filling date: 23 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB Filling date: 23 Sep 2025 Issue date: 17 Mar 2022 |
Application | Utility: N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 Filling date: 23 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: Pharmaceutical Composition Filling date: 23 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: ORAL FORMULATIONS OF BRANAPLAM Filling date: 23 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: MACROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF DISEASE Filling date: 23 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: 5-HYDROXY-7-OXABICYCLO[2.2.1]HEPTANE-2-CARBOXAMIDE DERIVATIVES FOR INDUCING CHONDROGENESIS FOR TREATING JOINT DAMAGE Filling date: 23 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: N-SUBSTITUTED TETRAHYDROTHIENOPYRIDINE DERIVATIVES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR Filling date: 23 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: 1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS Filling date: 23 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: USE OF IL-1BETA BINDING ANTIBODIES Filling date: 23 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: CD22 CHIMERIC ANTIGEN RECEPTOR (CAR) THERAPIES Filling date: 23 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: Amino Pyrimidine Derivatives Filling date: 23 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: ANTIBODY-CYTOKINE ENGRAFTED PROTEINS AND METHODS OF USE FOR IMMUNE RELATED DISORDERS Filling date: 23 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: Fused Tricyclic Pyridazinone Compounds Useful to Treat Orthomyxovirus Infections Filling date: 23 Sep 2025 Issue date: 10 Feb 2022 |
Showing 50 to 100 of 676 patents.